To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
17 Newest Market Studies about the topic pulmonary arterial hypertension
rssIntroduction GlobalData’s pharmaceuticals report, “Letairis (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020” provides Letairis sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive ...
Introduction GlobalData’s pharmaceuticals report, “Remodulin (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020” provides Remodulin sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, ...
Introduction GlobalData’s pharmaceuticals report, “Tracleer (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020” provides Tracleer sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive ...
Introduction GlobalData’s pharmaceuticals report, “Macitentan (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020” provides Macitentan sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, ...
Introduction GlobalData’s pharmaceuticals report, “Veletri (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020” provides Veletri sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive ...
Introduction GlobalData’s pharmaceuticals report, “Revatio (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020” provides Revatio sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive ...
Introduction Global Markets Direct’s, 'Pulmonary Arterial Hypertension - Pipeline Review, Q2 2011', provides an overview of the Pulmonary Arterial Hypertension therapeutic pipeline. This report provides information on the therapeutic development for Pulmonary Arterial Hypertension, complete ...
